Stay updated with breaking news from Adaptdx Pro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-month data from its LIGHTSITE III, multi-center clinical trial
Seattle, WA (PRWEB) September 15, 2022 -- Fast Company has honored Artefact, a design and strategy firm with a mission to create better futures, as a winner
/PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, is proud...
SEATTLE, July 26, 2022 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for
/PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today...